IGSF10 is a RET antagonist regulating Ewing sarcoma growth and GnRH neuron migration
Cell Reports · 2025
DOI: 10.1016/j.celrep.2025.116025 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Reports, 2025. Verfasst von Panneerselvam Jayabal und 10 weiteren Autor:innen. Beteiligte Einrichtung: Greehey Children's Cancer Research Institute, The University of Texas Health Science Center, San Antonio, TX 78229, USA. Hauptthemen laut MEDLINE: Sarcoma, Ewing, Gonadotropin-Releasing Hormone, Neurons, Proto-Oncogene Proteins c-ret. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, NIH HHS, NCRR NIH HHS.
Abstract (Originalsprache)
RET is a receptor tyrosine kinase that plays important roles in development, cancers, and Parkinson's disease. Here, we identify immunoglobulin superfamily member 10 (IGSF10) as a RET antagonist. We show that Ewing sarcoma depends on IGSF10 and that IGSF10 prevents RET-mediated activation of cdc42, a Rho family G protein and a key regulator of Ewing sarcoma growth as well as cell migration. We demonstrate that IGSF10 binds RET and GAS1, a cell surface RET inhibitor, and assembles an inhibitory RET-GAS1 complex, preventing a stimulatory RET-GFRA complex. IGSF10 mutations are associated with delayed puberty, and IGSF10 is shown to be necessary for the proper migration of gonadotropin-releasing hormone (GnRH) neurons. We show that the IGSF10-RET-GAS1-cdc42 pathway regulates migration of GnRH neurons and that IGSF10 mutants linked to delayed puberty are defective in RET-cdc42 regulation. These results reveal a critical role of IGSF10 as a RET antagonist in Ewing sarcoma and GnRH neurons.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Greehey Children's Cancer Research Institute, The University of Texas Health Science Center, San Antonio, TX 78229, USA.
- Cellular and Developmental Neurobiology Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892, USA.
- Greehey Children's Cancer Research Institute, The University of Texas Health Science Center, San Antonio, TX 78229, USA; Department of Population Health Sciences, The University of Texas Health Science Center, San Anton…
- Mays Cancer Center, The University of Texas Health Science Center, San Antonio, TX 78229, USA; Department of Biochemistry and Structural Biology, The University of Texas Health Science Center, San Antonio, TX 78229, USA.
- Greehey Children's Cancer Research Institute, The University of Texas Health Science Center, San Antonio, TX 78229, USA; Mays Cancer Center, The University of Texas Health Science Center, San Antonio, TX 78229, USA; Dep…
Förderung
- NCI NIH HHS
- NIH HHS
- NCRR NIH HHS
- Intramural NIH HHS
- William and Ella Owens Medical Research Foundation
- National Institutes of Health
- National Institutes of Health Office of the Director
- National Institute of Neurological Disorders and Stroke
Zitieren
APA
Jayabal, P., Ma, X., Akram, M., Bow, H., Mandal, P., Mansano, N., Chen, Y., Weintraub, S. T., Houghton, P. J., Wray, S., & Shiio, Y. (2025). IGSF10 is a RET antagonist regulating Ewing sarcoma growth and GnRH neuron migration. Cell Reports. https://doi.org/10.1016/j.celrep.2025.116025
Vancouver
Jayabal P, Ma X, Akram M, Bow H, Mandal P, Mansano N, et al. IGSF10 is a RET antagonist regulating Ewing sarcoma growth and GnRH neuron migration. Cell Reports. 2025. doi:10.1016/j.celrep.2025.116025
BibTeX
@article{Jayabal2025,
author = {Jayabal, Panneerselvam and Ma, Xiuye and Akram, Maleeha and Bow, Hannah and Mandal, Pranay and Mansano, Naira and Chen, Yidong and Weintraub, Susan T and Houghton, Peter J and Wray, Susan and Shiio, Yuzuru},
title = {IGSF10 is a RET antagonist regulating Ewing sarcoma growth and GnRH neuron migration},
journal = {Cell Reports},
year = {2025},
doi = {10.1016/j.celrep.2025.116025}
}
EUVIMED